Edition:
United States

Profile: Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

698.05INR
20 Jan 2017
Change (% chg)

Rs-16.60 (-2.32%)
Prev Close
Rs714.65
Open
Rs711.30
Day's High
Rs719.25
Day's Low
Rs695.00
Volume
1,137,000
Avg. Vol
2,171,157
52-wk High
Rs895.00
52-wk Low
Rs582.00

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergies and anti-diabetics. It is engaged in developing a range of oncology and hormonal products. It is also developing inhalation and dermatology products, such as pressurized metered-dose inhaler (pMDI). It markets its products through chain stores in the United States. It has developed over three injectable penem products. The Company, through its subsidiary, manufactures and sells nutritional supplements. It has over 10 manufacturing units and approximately two research and development centers. The Company, in addition to marketing its products domestically, also markets its products globally in over 150 countries.

Company Address

Aurobindo Pharma Ltd

Water Mark Building,, Plot No. 1
Survey no.9, Kondapur, Hitech Ci
Hyderabad,Telangana
HYDERABAD     500084
P: +9140.66725000
F: +9140.23741080

Company Web Links